tradingkey.logo
tradingkey.logo
Search

HeartSciences Inc

HSCS
Add to Watchlist
2.320USD
+0.240+11.54%
Close 07-31 16:00ETQuotes delayed by 15 min
7.40MMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-31
Previous score
8.00
Change
0
The current earnings forecast score of HeartSciences Inc is 8.00, ranking 69 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 13.50, with a high of 15.00 and a low of 12.00.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
10.000
Target Price
+362.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
HeartSciences Inc
HSCS
2
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
29
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is HeartSciences Inc's expected revenue for the next quarter?

HeartSciences Inc's expected revenue is 50.00K.

What is HeartSciences Inc's price target?

Analysts forecast that HeartSciences Inc's price target is USD 13.50, with the highest forecast at USD 15.00 and the lowest forecast at USD 12.00.

How have HeartSciences IncHSCS's recent earnings per share performed?

The market expectation was USD -0.88, while HeartSciences IncHSCS's earnings per share (EPS) for the previous quarter was USD -0.63. EPS for the next quarter is expected at USD -0.77.

What is the analyst rating for HeartSciences Inc?

Based on the ratings of HeartSciences Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.